IRadimed Corp.
No trades
No trades
Price target
100.440.000.00%
The 2 analysts offering 1-year price forecasts have a max estimate of — and a min estimate of —.
Analyst rating
Based on 2 analysts giving stock ratings in the past 3 months.
EPS
Reported
Estimate
Metrics
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Metrics
Reported
Estimate
Surprise
This is not investment advice and doesn't take into account your personal circumstances. It isn't a recommendation to buy, sell, or hold any asset. See the Terms of Use and always do your own research.
Frequently asked questions
The current price of 46K is 78.5 EUR — it has decreased by −0.63% in the past 24 hours. Watch IRadimed Corp. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange IRadimed Corp. stocks are traded under the ticker 46K.
46K stock has fallen by −4.27% compared to the previous week, the month change is a −9.25% fall, over the last year IRadimed Corp. has showed a 30.83% increase.
We've gathered analysts' opinions on IRadimed Corp. future price: according to them, 46K price has a max estimate of 102.14 EUR and a min estimate of 98.74 EUR. Watch 46K chart and read a more detailed IRadimed Corp. stock forecast: see what analysts think of IRadimed Corp. and suggest that you do with its stocks.
46K stock is 0.64% volatile and has beta coefficient of 0.34. Track IRadimed Corp. stock price on the chart and check out the list of the most volatile stocks — is IRadimed Corp. there?
Today IRadimed Corp. has the market capitalization of 1.03 B, it has decreased by −5.71% over the last week.
Yes, you can track IRadimed Corp. financials in yearly and quarterly reports right on TradingView.
IRadimed Corp. is going to release the next earnings report on Oct 29, 2026. Keep track of upcoming events with our Earnings Calendar.
46K earnings for the last quarter are 0.40 EUR per share, whereas the estimation was 0.39 EUR resulting in a 4.55% surprise. The estimated earnings for the next quarter are 0.47 EUR per share. See more details about IRadimed Corp. earnings.
IRadimed Corp. revenue for the last quarter amounts to 17.92 M EUR, despite the estimated figure of 17.82 M EUR. In the next quarter, revenue is expected to reach 20.14 M EUR.
46K net income for the last quarter is 4.57 M EUR, while the quarter before that showed 5.04 M EUR of net income which accounts for 0.00% change. Track more IRadimed Corp. financial stats to get the full picture.
Yes, 46K dividends are paid quarterly. The last dividend per share was 0.17 EUR. As of today, Dividend Yield (TTM)% is 0.80%. Tracking IRadimed Corp. dividends might help you take more informed decisions.
IRadimed Corp. dividend yield was 0.70% in 2025, and payout ratio reached 38.88%. The year before the numbers were 0.82% and 29.91% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Aug 8, 2026, the company has 166 employees. See our rating of the largest employees — is IRadimed Corp. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. IRadimed Corp. EBITDA is 25.55 M EUR, and current EBITDA margin is 32.59%. See more stats in IRadimed Corp. financial statements.
Like other stocks, 46K shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade IRadimed Corp. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So IRadimed Corp. technincal analysis shows the sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating IRadimed Corp. stock shows the buy signal. See more of IRadimed Corp. technicals for a more comprehensive analysis.